Plain-English translation of NCT06707129 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying people with non-alcoholic fatty liver disease (NAFLD) and moderate to advanced liver scarring (fibrosis). Researchers want to create new, precise standards for measuring whether liver scarring can actually reverse or improve when patients make lifestyle changes over 1 to 3 years. This could help doctors better track whether treatments and lifestyle modifications are truly working.
Currently, doctors don't have clear, standardized ways to measure whether liver fibrosis actually improves in patients. By establishing better measurement criteria, this research could help guide treatment decisions and give patients clearer evidence of whether their efforts to improve liver health are working.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic every 6 months for 1 to 3 years. At each visit, you'll have a physical exam, blood tests, imaging scans, and body measurements. You'll also answer questions about your diet, sleep, exercise, and daily habits, and receive guidance on healthy lifestyle changes. At the end of the study period, you'll undergo a second liver biopsy so doctors can compare your liver tissue to your baseline biopsy and see if the scarring has improved.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China
Sponsor
Beijing Municipal Administration of Hospitals
Enrollment target
~50 participants
Started
August 2024
Primary completion
August 2027
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Minghui Li
Beijing Municipal Administration of Hospitals
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.